Abstract:Circular RNAs (circRNAs) are highly stable regulators, often accumulated in mammalian brains and thought to serve as “memory molecules” that govern the long process of aging. Mounting evidence demonstrated circRNA dysregulation in the brains of Alzheimer’s disease (AD) patients. However, whether and how circRNA dysregulation underlies AD progression remains unexplored. We combined Poly(A)-tailing/RNase R digestion experimental approach with CARP, our published computational framework using pseudo-reference alignment for more sensitive and accurate circRNA detection to identify genome-wide circRNA dysregulation and their downstream pathways in the 5xFAD mouse cerebral cortex between 5 and 7 months of age, a critical window marks the transition from reversible to irreversible pathogenic progression. Dysregulated circRNAs and pathways associated with disease progression in 5xFAD cortex were systematically compared with circRNAs affected in postmortem subcortical areas of a large human AD cohort. A top-ranked circRNA conserved and commonly affected in AD patients and 5xFAD mice was depleted in cultured cells to examine AD-relevant molecular and cellular changes. We discovered genome-wide circRNA alterations specifically in 5xFAD cortex associated with AD progression, many of which are commonly dysregulated in the subcortical areas of AD patients. Among these circRNAs, circGigyf2 is highly conserved and showed the highest net reduction specifically in the 7-month 5xFAD cortex. CircGIGYF2 level in AD patients’ cortices negatively correlated with dementia severity. Mechanistically, we found multiple AD-affected splicing factors that are essential for circGigyf2 biogenesis. Functionally, we identified and experimentally validated the conserved roles of circGigyf2 in sponging AD-relevant miRNAs and AD-associated RNA binding proteins (RBPs), including the cleavage and polyadenylation factor 6 (CPSF6). Moreover, circGigyf2 downregulation in AD promoted silencing activities of its sponged miRNAs and enhanced polyadenylation site processing efficiency of CPSF6 targets. Furthermore, circGigyf2 depletion in a mouse neuronal cell line dysregulated circGigyf2-miRNA and circGigyf2-CPSF6 axes and potentiated apoptotic responses upon insults, which strongly support the causative roles of circGigyf2 deficiency in AD neurodegeneration. Together, our results unveiled brain circRNAs associated with irreversible disease progression in an AD mouse model that is also affected in AD patients and identified novel molecular mechanisms underlying the dysregulation of conserved circRNA pathways contributing to AD pathogenesis.

Regulatory Mechanism of Circular RNAs in Neurodegenerative Diseases

Emerging Clues of Regulatory Roles of Circular RNAs Through Modulating Oxidative Stress: Focus on Neurological and Vascular Diseases.

The Clinical Perspective of Circular RNAs in Neurodegenerative Diseases: Potential Diagnostic Tools and Therapeutic Targets

Current Status and Potential Role of Circular RNAs in Neurological Disorders

The Role of circRNAs in the Pathological Mechanisms of Alzheimer's Disease and May Serve as Potential Biomarkers

Identification of pathological pathways centered on circRNA dysregulation in association with irreversible progression of Alzheimer's disease

Circular RNAs: Diagnostic and Therapeutic Perspectives in CNS Diseases

Current status and potential role of circular RNA s in neurological disorders

Functional Roles of Circular RNAs in Alzheimer’s Disease

circRNAs:post-transcription regulation in cerebrovascular diseases

Progress in Understanding the Relationship Between Circular RNAs and Neurological Disorders

Circular RNAs: New Players Involved in the Regulation of Cognition and Cognitive Diseases

Physiological and Pathological Functions of Circular RNAs in the Nervous System

Mini Review: Circular RNAs As Potential Clinical Biomarkers for Disorders in the Central Nervous System

CircRNAs: A New Perspective of Biomarkers in the Nervous System

The emerging role of circular RNAs in Parkinson’s disease

Circular RNAs: A Novel Player in Development and Disease of the Central Nervous System.

Identification of Pathological Pathways Centered on Circrna Dysregulation in Association with Irreversible Progression of Alzheimer’s Disease

Circular Rnas In Early Brain Development And Their Influence And Clinical Significance In Neuropsychiatric Disorders

A Summary of Circular RNAs in Alzheimer's Disease

CircRNA-ceRNA Network Revealing the Potential Regulatory Roles of CircRNA in Alzheimer’s Disease Involved the Cgmp-Pkg Signal Pathway